CD34 + CD38 − and CD34 + HLA-DR − cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation

By Zubair Ac   Kao G   Daley H   Schott D   Freedman A   Ritz J  

Cytotherapy, Vol. 8, Iss. 4, 2006-08 ,pp. : 399-407

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Autologous transplantation: the viable transplanted CD34 + cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34 + cell dose measured pre-freeze in patients that receive more than 2×10 6 CD34 + cells/kg

By Abrahamsen JF   Wentzel-larsen T   Bruserud Ø  

Cytotherapy, Vol. 6, Iss. 4, 2004-08 ,pp. : 356-362

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Aldehyde dehydrogenase as an alternative to enumeration of total and viable CD34⁺⁺ cells in autologous hematopoietic progenitor cell transplantation

By Veeraputhiran Muthu   Katragadda Lakshmikanth   Balamurugan Appathurai   Cottler-Fox Michele  

Cytotherapy, Vol. 13, Iss. 10, 2011-11 ,pp. : 1256-1258

Ashgate Publishing Ltd

Access to resources Recommend Favorite

High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer

By Braunschweig I.   Mirza N.Q.   Rondon G.   Lauppe J.   Mehra R.   Gajewski J.   Körbling M.   Huh Y.O.   Geisler D.   Gee A.P.   Champlin R.   Przepiorka D.  

Cytotherapy, Vol. 2, Iss. 2, 2000-02 ,pp. : 105-110

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Autologous transplantation of CD133 + BM-derived stem cells as a therapeutic option for dilatative cardiomyopathy

By Ghodsizad A   Ruhparwar A   Marktanner R   Borowski A   Mohammad Hasani Mr   Poll L   Vshivkov I   Stoldt V   Voelkel T   Piechaczek C   Burchardt Er   Stockschlaeder M   Sucker C   Gams E   Klein Hm  

Cytotherapy, Vol. 8, Iss. 3, 2006-05 ,pp. : 308-310

Ashgate Publishing Ltd

Access to resources Recommend Favorite